<DOC>
	<DOCNO>NCT02102620</DOCNO>
	<brief_summary>Objective - evaluate effectiveness tolerance intra-articular injection ( IAI ) hexacetonide triamcinolone ( HT ) treatment osteoarthritis ( OA ) interphalangeal joint . Design : randomize , control , double-blinded study Materials method : sixty patient randomize : TH / lidocaine ( LD ) group ( n=30 ) underwent IAI symptomatic interphalangeal joint HT ( 20mg/ml ) LD 2 % LD group ( n=30 ) receive IAI LD . Patients assessed baseline , 1 , 4 , 8 12 week blind observer . The following parameter regard affect joint assess : pain rest ( VASr ) ; pain movement ( VASm ) ; pain ( VAS ) 48 hour procedure ; swell ( VASs ) ; goniometry ; grip pinch strength ; hand function ; treatment improvement ; daily requirement paracetamol incidence type local side effect procedure .</brief_summary>
	<brief_title>Corticosteroid Intra-articular Injection Hands Osteoarthritis</brief_title>
	<detailed_description>Background The aim study evaluate effectiveness tolerance medium-term IAI corticosteroid HT treatment OA proximal interphalangeal joint ( PIP ) distal interphalangeal joint ( DIP ) joint clinical functional parameter . Studies evaluate effectiveness intra-articular therapy patient hand OA heterogeneous , either address different type joint time , wear unusual drug , fail placebo group , use soluble corticosteroid use corticosteroid . Design A randomized , prospective , control , double-blinded , intention treat study perform . Sample Patients collect outpatient clinic Federal University Sao Paulo , August 2011 August 2012 . A total 60 patient randomize two group 30 patient . The patient fulfill follow inclusion criterion : diagnosis PIP DIP hand OA accord American College Rheumatology criterion , age great 40 year , pain least one PIP DIP hand joint 3-8 cm Visual Analog Scale pain ( VAS pain rest 0-10cm ) . Patients change corticosteroid nonsteroidal antiinflammatory drug last thirty day ; change chondroprotective drug last two month ; IAI corticosteroid study joint last three month ; change hand OA treatment last two month ( rehabilitation , acupuncture others ) ; suspicion local systemic infection ; hand x-ray suggesting another etiology hand arthropathy ( psoriatic arthritis , microcrystalline arthropathy , deposit disease ) severe coagulation disorder . Intervention Patients randomize two group . The study group call hexacetonide triamcinolone / lidocaine ( TH / LD ) control group , call lidocaine ( LD ) . Patients TH / LD group underwent treatment scheme symptomatic interphalangeal ( IP ) joint compose IAI HT ( 20mg/ml ) 2 % lidocaine without vasoconstrictor . The IAI realize 0.3 ml dose ( 6mg ) HT PIP 0.2 ml ( 4 mg ) HT DIP , always associate 0.1 mL 2 % lidocaine . The LD group patient underwent IAI 2 % lidocaine without vasoconstrictor symptomatic IP joint . Paracetamol 750 mg / tablet also use require 12 week follow-up ( 03 tablet per day ) group . Both group patient underwent one IAI symptomatic joint single occasion . The procedure two group perform blindly rheumatologist 10 year experience interventional rheumatology rigorous antisepsis alcoholic 0.5 % chlorhexidine . Sterile insulin syringe BD ™ Ultra Fine needle 8 mm x 0.3 mm 30 G ) use patient . The anatomical place use needle entry locate dorsal - lateral joint aspect 14 ( Figure 1 ) . After procedure , inject joint immobilized 48 hour , group . Assessment All patient data report evaluation form . The data collect : age , sex , race , use chondroprotective drug , anti-inflammatory / analgesic drug . Hands x-ray performed anteroposterior view study inclusion . The measurement do accord method Kellgren Lawrence use evaluate homogeneity sample . Five assessment evaluation schedule total 12 week follow-up . Patients assess T0 ( intervention ) , T1 , T4 , T8 T12 week intervention . The assessment carry `` blind '' assessor , trained assessment instrument . This study intention treat study . The last observation carry forward case discontinuation . Clinical assessment The following parameter assess group : - Visual analogue scale ( VAS ) rest pain ( VASr 0- 10cm ) ; - VAS movement pain ( VASm 0- 10cm ) ; - VAS joint swelling ( VASs 0- 10cm ) ; - Joint goniometry flexion ( degree range motion ) ; - Analgesic consumption intervention ( paracetamol daily average ) ; - Grip strength use Jamar® dynamometer ( kgf ) obtain average three attempt ; - Pinch strength use dynamometer Pinch Gauge ( kgf ) - obtain average three trial three type pinch : tip , key tripod 16 ; - Hand function assess COCHIN questionnaire AUSCAN Index use sub-scales pain , stiffness hand function ; - Treatment improvement scale vary 5 point ( much bad , bad , unchanged , little improvement much improve ) ; - Side effect follow procedure ( atrophy / cutaneous hypochromia joint instability ) ; - Worsening pain IAI measure VAS ( post IAI VAS 0- 10cm ) 48 hour procedure ( report T1 ) group . Sample Size Using VAS pain primary study variable , consider standard deviation equal 1.5 point , base previous work , use ANOVA repeat measure statistical method calculation sample , power 90 % , 5 % significance detectable difference 2.0 point VAS pain scale , measure 5 time time two independent group , investigator find sample 24 patient group . Considering possible loss 20 % patient time , investigator start study 30 patient group . Randomization Patients randomize use MINITAB 14.0 software , secret allocation guarantee opaque seal envelope . The responsible inclusion patient prior access randomization list ; responsible verifying patient within inclusion exclusion criterion study procedure refer patient evaluators another room , medication prepare . Sample Blinding Only responsible inclusion / exclusion patient access group patient belong , enrollment . Evaluators responsible procedure access information . This blind relative impair , since volume use infiltration group TH / LD substantially great used LD group . However responsible procedure responsible recruitment/allocation evaluation sample . Regarding essay evaluator identify problem relate `` blinding '' study . Statistical method SPSS software version 17.0 ( Chicago , IL ) use perform statistical analysis . The descriptive statistic ( mean , standard deviation , confidence interval 95 % ) use characterize patient group . Continuous variable 2 group baseline compare use Student test ( normally distribute variable ) Mann-Whitney test ( variable distribution consider normal ) . Categorical variable evaluate use chi-square test . To assess response intervention , analysis variance ( ANOVA ) repeat measure use intragroup intergroup analysis time . This study consider statistically significant p value &lt; 0.05 .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Hand OA Age 40 Visual analogic scale ( VAS ) pain rest 38cm Signed inform consent term Change use oral corticosteroid nonsteroidal antiinflammatory ( NSAID ) last 30 day Change drug OA last two month IAI joint last three month Any change treatment OA hand last two month Suspicion local systemic infection , pregnancy Hands Xray suggest arthropathy interphalanges etiology Serious coagulation disorder</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>intra-articular injection</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>Interphalangeal joint</keyword>
</DOC>